IgG4-related thyroid disease
disease diseaseOn this page
Also known as Riedel diseaseRiedel fibrosing thyroiditisRiedel thyroiditisRiedel's fibrosing thyroiditis
Summary
IgG4-related thyroid disease (MONDO:0018992) is a disease. A subtype of autoimmune thyroid disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: 1-9 / 100 000 (United States) [Orphanet-validated]
- Phenotypes (HPO): 25
Clinical features
Epidemiology
Prevalence records
1 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Annual incidence | 1-9 / 100 000 | 1.06 | United States | Validated |
Signs & symptoms
Clinical features (HPO)
25 HPO clinical features (Orphanet curated; top 25 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000853 | Goiter | Very frequent (80-99%) |
| HP:0100646 | Thyroiditis | Very frequent (80-99%) |
| HP:0000821 | Hypothyroidism | Frequent (30-79%) |
| HP:0000872 | Hashimoto thyroiditis | Frequent (30-79%) |
| HP:0025379 | Anti-thyroid peroxidase antibody positivity | Frequent (30-79%) |
| HP:0032069 | Anti-thyroglobulin antibody positivity | Frequent (30-79%) |
| HP:0032300 | Increased circulating IgG4 level | Frequent (30-79%) |
| HP:0001605 | Vocal cord paralysis | Occasional (5-29%) |
| HP:0002015 | Dysphagia | Occasional (5-29%) |
| HP:0002777 | Tracheal stenosis | Occasional (5-29%) |
| HP:0002901 | Hypocalcemia | Occasional (5-29%) |
| HP:0002960 | Autoimmunity | Occasional (5-29%) |
| HP:0005994 | Nodular goiter | Occasional (5-29%) |
| HP:0009798 | Euthyroid goiter | Occasional (5-29%) |
| HP:0100647 | Graves disease | Occasional (5-29%) |
| HP:0002664 | Neoplasm | Excluded (0%) |
| HP:0012393 | Allergy | Excluded (0%) |
| HP:0005200 | Retroperitoneal fibrosis | Very rare (<1-4%) |
| HP:0011784 | Thyrotoxicosis with diffuse goiter | Very rare (<1-4%) |
| HP:0012503 | Abnormality of the pituitary gland | Very rare (<1-4%) |
| HP:0030991 | Sclerosing cholangitis | Very rare (<1-4%) |
| HP:0031281 | Sialadenitis | Very rare (<1-4%) |
| HP:0032039 | Abnormality of the ocular adnexa | Very rare (<1-4%) |
| HP:0045026 | Abnormality of the mediastinum | Very rare (<1-4%) |
| HP:0100732 | Pancreatic fibrosis | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | IgG4-related thyroid disease |
| Mondo ID | MONDO:0018992 |
| Orphanet | 64744 |
| DOID | DOID:14351 |
| ICD-11 | 1357889668 |
| NCIT | C35827 |
| SNOMED CT | 89024000 |
| UMLS | C0154162 |
| MedGen | 509536 |
| GARD | 0018866 |
| MedDRA | 10039142 |
| Is cancer (heuristic) | no |
Also known as: Riedel disease · Riedel fibrosing thyroiditis · Riedel thyroiditis · Riedel’s fibrosing thyroiditis
Disease family
This is a subtype of autoimmune thyroid disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › endocrine system disorder › autoimmune disorder of endocrine system › autoimmune thyroid disease › IgG4-related thyroid disease
Related subtypes (4): Graves disease, atrophic thyroiditis, Hashimoto thyroiditis, postpartum thyroiditis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.